Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma
This study is ongoing, but not recruiting participants.
Study NCT00251394   Information provided by Dana-Farber Cancer Institute
First Received: November 8, 2005   Last Updated: May 1, 2009   History of Changes

No Study Results Posted for this Study
About Study Results Reporting
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2009
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)